MSP Recovery Claims, Series LLC v. Fresenius Medical Care Holdings, Inc.

131 F.4th 51
Court of Appeals for the First Circuit·Decided March 17, 2025·No. 23-1820·Published·Cited by 1 cases

Opinion

United States Court of Appeals For the First Circuit

No. 23-1820 MSP RECOVERY CLAIMS, SERIES LLC; MSPA CLAIMS 1 LLC; SERIES PMPI, Plaintiffs, Appellants,

v.

FRESENIUS MEDICAL CARE HOLDINGS, INC.; FRESENIUS USA, INC.;

FRESENIUS USA MANUFACTURING, INC.; FRESENIUS USA MARKETING, INC.; FRESENIUS USA SALES, INC.,

Defendants, Appellees.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Nathaniel M. Gorton, U.S. District Judge]

Before

Montecalvo, Lynch, and Kayatta, Circuit Judges.

Janpaul Portal, with whom Aida M. Landa, John W. Cleary, and MSP Recovery Law Firm were on brief, for appellants.

James F. Bennett, with whom Megan S. Heinsz, Hannah F.

Preston, Dowd Bennett LLP, Maria R. Durant, and Hogan Lovells US LLP were on brief, for appellees.

March 17, 2025

KAYATTA, Circuit Judge. Plaintiffs MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; and Series PMPI (collectively "MSP") filed the present suit in September 2018, six years after their claims first accrued in 2012. In the normal course, this delay would have rendered the suit untimely under all relevant statutes of limitations. MSP contends, however, that an earlier-filed putative class action tolled the statutes of limitations from 2013 through 2019 under the rule of American Pipe & Construction Co. v. Utah, 414 U.S. 538 (1974). The district court disagreed. For the following reasons, so do we.

I.

A.

Defendants Fresenius Medical Care Holdings, Fresenius USA, Fresenius USA Manufacturing, and Fresenius USA Marketing1 (collectively "Fresenius") manufacture and distribute GranuFlo, an acid concentrate used in hemodialysis treatments. On March 29, 2012, Fresenius issued a public memorandum explaining that GranuFlo could lead to cardiopulmonary arrest in certain patients and advising doctors to "exercise their best clinical judgment" when prescribing and administering treatments.

This announcement triggered a stream of wrongful death and personal injury lawsuits against Fresenius, including, as

1 Defendant Fresenius USA Sales dissolved in 2010 and is no longer a legal entity.

relevant here, a putative class action filed on March 21, 2013, in the Eastern District of Louisiana (the "Berzas action"). See Class Action Compl., Berzas v. Fresenius Med. Care Holdings, Inc., No. 13-cv-00529 (E.D. La. Mar. 21, 2023). The Berzas action was a "product liability action to recover damages for injuries sustained . . . as the direct and proximate result of the wrongful conduct of the Defendants in connection with the designing, developing, manufacturing, distributing, labeling, advertising, marketing, promoting, and selling of" GranuFlo and NaturaLyte (a related product). Id. at 2. The nine named plaintiffs sought damages for themselves and declared a desire to represent a class of

[a]ll consumers and third-party payors in the United States and its territories who, for purposes other than resale, purchased, reimbursed and/or paid for NATURALYTE and/or GRANUFLO from May 1, 2003 to present. For purposes of the Class definition, individuals and entities "purchased" NATURALYTE and/or GRANUFLO if they paid some or the entire purchase price.

Id. at 46. They alleged that GranuFlo and NaturaLyte were defective and that Fresenius had engaged in deceptive and unfair trade practices in marketing and distributing the products. Id. at 49–57.

The Berzas action was transferred to the District of Massachusetts as part of the consolidated multidistrict litigation ("MDL") of all GranuFlo claims. On February 13, 2014, the parties

entered into a revised case management order. Pursuant to that order, each Berzas plaintiff agreed to adopt the pleadings contained in a "Master Complaint" that "set forth the claims that individual Plaintiffs and/or the estates and/or heirs of deceased persons may assert against Defendants in this litigation." Each plaintiff further agreed to adopt and submit a "Short Form Complaint" that would incorporate the Master Complaint and "replace" that party's original complaint.

On March 18, 2014, five of the nine named Berzas plaintiffs filed Short Form Complaints on behalf of themselves and their deceased next of kin. Each of those five Short Form Complaints included a section specifying on whose behalf the claims were being brought and a checklist of the counts articulated in the Master Complaint that the specific action incorporated. Without fail, each of the complaints identified only the named plaintiff and/or that plaintiff's next of kin as the represented parties. The other four named plaintiffs filed stipulations of dismissal on June 27, 2014.

To recap, in June of 2014 the court record as to the Berzas action was clear: The Berzas plaintiffs no longer had before the court any request to pursue claims on behalf of any class. That apparent clarity, though, only lasted seven months. In January of 2015, the court stated that the 2014 adoption of the Master Complaint and the filing of the Short Form Complaint did

not "necessarily supersede[]" a plaintiff's original complaint "for purposes of motion to dismiss practice." The court noted that an amended complaint, once filed, typically replaces the complaint that came before. However, it suggested that the normal rule might not apply to the MDL context, where the Master Complaint served as a mere "administrative device."

Statements by counsel for both sides created further confusion. At a March 2, 2015 conference with the court, which the Berzas plaintiffs' counsel did not attend, the district court mentioned to MDL plaintiffs' counsel and defense counsel that the Judicial Panel on Multidistrict Litigation statistics showed no remaining GranuFlo class actions pending. Defense counsel replied that there were three such actions that he knew of off the top of his head, including Berzas. When asked why the class actions were still "hanging out there," defense counsel stated, "In all candor, I don't remember the specifics of Berzas. . . . I can certainly do some digging on those cases and get back to you about it." In light of that response, the court stated that it might revisit the issue and that it planned to "contact the Clerk at the Panel and say, 'We have got three class actions in this MDL.'"

In the next status conference on April 10, 2015, MDL plaintiffs' counsel said to the court that Berzas was a still- pending class action. He added that leadership counsel was nevertheless "not planning on moving for certification," and that

"these cases were filed, for the most part, with respect to the issue of equitable tolling for the purposes of the limitations period, and for now our preference is to just leave them as they are." The court asked if any of the cases had "tried to fit themselves into a Short Form?" Defense counsel responded that "there are Short Forms that have been filed on behalf of the individual[]named plaintiffs in every case except the Rodriguez case," and that "[i]n all of the other cases," a group that included Berzas, "Short Form Complaints have been filed, but the class action allegations were not imported into the Short Form Complaints."

Over the course of nearly five years, the Berzas plaintiffs took no action to move their claims forward, even as the entire MDL proceeding was assigned to a different district court judge. In 2016, the GranuFlo MDL parties reported to the district court that they had reached a private global settlement in principle that could resolve the "vast majority" of GranuFlo individual claims. After the deadline to opt in to the settlement fund had passed, the district court granted Fresenius's assented- to motion to sever the claims of all remaining plaintiffs in the Berzas action. The Berzas action was finally closed on April 30, 2019.

B.

Free access — add to your briefcase to read the full text and ask questions with AI

MSP Recovery Claims, Series LLC v. Fresenius Medical Care Holdings, Inc., 131 F.4th 51 (1st Cir. 2025).

131 F.4th 51 (MSP Recovery Claims, Series LLC v. Fresenius Medical Care Holdings, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related